Dr. Plodkowski is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
12395 El Camino Real
Suite 317
San Diego, CA 92130Phone+1 858-794-1250
Education & Training
- University of HawaiiResidency, Internal Medicine, 1995 - 1997
- Drexel University College of Medicine/Hahnemann University HospitalResidency, Internal Medicine, 1994 - 1995
- MCP-Hahnemann College of MedicineClass of 1994
Certifications & Licensure
- OR State Medical License 1998 - Present
- CA State Medical License 1998 - 2026
- HI State Medical License 1997 - 2026
- NV State Medical License 2002 - 2025
- WA State Medical License 1998 - 2012
- FL State Medical License 1997 - 2005
- TX State Medical License 1997 - 2004
- American Board of Obesity Medicine Obesity Medicine
- Join now to see all
Clinical Trials
- Zonisamide SR Plus Bupropion SR Combination Therapy in Subjects With Obesity Start of enrollment: 2008 Jul 01
- Weight Loss and Abdominal Fat Responses to Different Diet Compositions Start of enrollment: 2009 Apr 01
Publications & Presentations
PubMed
- 868 citationsAMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OB...W. Timothy Garvey, Jeffrey I. Mechanick, Elise M. Brett, Alan J. Garber, Daniel L. Hurley
Endocrine Practice. 2016-08-03 - 285 citationsEffects of naltrexone sustained-release/bupropion sustained-release combination therapy on body weight and glycemic parameters in overweight and obese patients with ty...Priscilla Hollander, Alok Gupta, Raymond A Plodkowski, Frank L. Greenway, Harold Bays
Diabetes Care. 2013-12-01 - 566 citationsEffect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trialFrank L. Greenway, Ken Fujioka, Raymond A Plodkowski, Sunder Mudaliar, Maria Guttadauria
Lancet. 2010-08-21
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: